Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, December 3 2016 3:21am ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
Latest News
Saturday, Dec 3, 2016
·INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm
- 2 hours, 51 minutes ago
Friday, Dec 2, 2016
·SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Lannett Company, Inc. of Class Action Lawsuit and Upcoming Deadline - LCI
PR Newswire - Fri 3:56 pm ET
·INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Diplomat Pharmacy, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2017 – DPLO
GlobeNewswire - Fri 10:45 am ET
·DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mylan N.V. (MYL) and Lead Plaintiff Deadline: December 12, 2016
- Fri 10:07 am ET
·Allergan & Amgen Looking for Approvals (AGN, AMGN)
at Investopedia - Fri 9:53 am ET
·Amgen, Allergan apply for European nod for Avastin biosimilar
Reuters - Fri 9:33 am ET
·Amgen And Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215, A Biosimilar Candidate To Bevacizumab
PR Newswire - Fri 9:00 am ET
·Catalent Announces Pricing of Private Offering of Euro-Denominated Senior Unsecured Notes Due 2024
Business Wire - Fri 7:58 am ET
·Allergan Provides Update on Accelerated Share Repurchase (ASR) Program
PR Newswire - Fri 7:30 am ET
·Allergan settles patent litigation with Zydus Pharma and Cadila regarding ulcerative colitis treatment
at MarketWatch - Fri 7:20 am ET
·Allergan Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation
PR Newswire - Fri 7:00 am ET
·INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Lannett Company, Inc. and Encourages Investors with Losses to Contact the Firm
- Thu 7:05 pm ET
·Ontario health ministry to probe alleged Costco pharmacy kickbacks
Reuters - Thu 6:38 pm ET
·Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Lannett Company, Inc.
PR Newswire - Thu 6:00 pm ET
·Diplomat to Dispense Multiple Myeloma Combination Drug DARZALEX®
PR Newswire - Thu 4:30 pm ET
Thursday, Dec 1, 2016
·SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Diplomat Pharmacy, Inc. and Encourages Investors with Losses to Contact the Firm
- Thu 2:27 pm ET
·Allergan CEO expects drug industry to face pricing heat from Trump
Reuters - Thu 2:22 pm ET
·The EpiPen-maker's CEO knows who's responsible for soaring drug costs — and it's not her
Business Insider - Thu 1:57 pm ET
·The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mylan NV Investors
Business Wire - Thu 1:34 pm ET
·Mylan CEO Hopes EpiPen Furor Leads To 'Price Transparency'
at Forbes.com - Thu 11:47 am ET
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?